We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WRAC
3551
DELISTED
Williams Rowland Acquisition Corp.
WRAC
-1,048,090
Closed -$10.6M
LCA
3552
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
-2,443,554
Closed -$24M
SLAC
3553
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
-664,542
Closed -$6.53M
SIEN
3554
DELISTED
Sientra, Inc.
SIEN
-6,718
Closed -$43K
NSTG
3555
DELISTED
NanoString Technologies, Inc.
NSTG
-48,544
Closed -$621K
WTER
3556
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
-52,492
Closed -$267K
OTEC
3557
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
-482,590
Closed -$4.92M
ELIQ
3558
DELISTED
Electriq Power Holdings, Inc.
ELIQ
-1,908,062
Closed -$18.8M
LMDXW
3559
CALL
DELISTED
LumiraDx Limited Warrant
LMDXW
-168,400
Closed -$172K
OHAAW
3560
CALL
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
-190,380
Closed -$1.89M
OHAA
3561
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
-531,430
Closed -$5.28M
PNT
3562
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-115,102
Closed -$890K
LVOXW
3563
CALL
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
-570,364
Closed -$1.68M
NOGNW
3564
CALL
DELISTED
Nogin, Inc. Warrant
NOGNW
-209,910
Closed -$284K
VAPO
3565
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-33,782
Closed -$424K
NM
3566
DELISTED
Navios Maritime Holdings Inc.
NM
-198,264
Closed -$376K
TBCP
3567
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
-1,637,045
Closed -$16.1M
IPVF
3568
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
-767,230
Closed -$7.51M
CFIV
3569
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
-1,891,309
Closed -$18.8M
GETR.WS
3570
CALL
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
-192,362
Closed -$1.89M
UPH.WS
3571
CALL
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
-13,083
Closed -$7K
MTRY
3572
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
-12,299
Closed -$124K
OPAD.WS
3573
CALL
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
-79,555
Closed -$96K
ARGO
3574
DELISTED
Argo Group International Holdings, Ltd.
ARGO
-182,930
Closed -$3.52M
HLGN.WS
3575
CALL
DELISTED
Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
-300,000
Closed -$558K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.